Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

KaloBios Pharmaceuticals Company Profile (NASDAQ:KBIO)

Earnings History for KaloBios Pharmaceuticals (NASDAQ:KBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare
5/8/2014($0.37)($0.32)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
3/13/2014($0.41)($0.25)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3 13$0.00($0.47)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)